April 29

2015

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Reuters (subscription required)

Home
News
Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Related People

Brian W. Nolan

In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

Related Capabilities

Practices –

Industries –

Life Sciences

News

February 03

2023

Mayer Brown advises Crédit Agricole wealth management arm, Indosuez, on acquisition of majority stake in Wealth Dynamix
January 19

2023

Chambers Asia Pacific and Greater China 2023 rank Mayer Brown in 35 practice areas and recognize 41 lawyers
January 16

2023

Legal 500 Asia Pacific 2023 ranks Mayer Brown in 40 practice categories and recognizes 36 lawyers
January 09

2023

Mayer Brown advises Marlin Equity Partners on the acquisition of a majority stake in Cloud Technology Solutions Group
December 19

2022

The IP News that Mattered Most in 2022, According to You

IPWatchdog